These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Browning MF; Levy HL; Wilkins-Haug LE; Larson C; Shih VE Obstet Gynecol; 2006 Jan; 107(1):115-20. PubMed ID: 16394048 [TBL] [Abstract][Full Text] [Related]
26. Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Tsina EK; Marsden DL; Hansen RM; Fulton AB Arch Ophthalmol; 2005 Aug; 123(8):1143-6. PubMed ID: 16087854 [No Abstract] [Full Text] [Related]
27. Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. Morel CF; Watkins D; Scott P; Rinaldo P; Rosenblatt DS Mol Genet Metab; 2005; 86(1-2):160-71. PubMed ID: 16150626 [TBL] [Abstract][Full Text] [Related]
28. An infant and mother with severe B Sobczyńska-Malefora A; Ramachandran R; Cregeen D; Green E; Bennett P; Harrington DJ; Lemonde HA Eur J Clin Nutr; 2017 Aug; 71(8):1013-1015. PubMed ID: 28537576 [TBL] [Abstract][Full Text] [Related]
29. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Slot WB; Merkus FW; Van Deventer SJ; Tytgat GN Gastroenterology; 1997 Aug; 113(2):430-3. PubMed ID: 9247460 [TBL] [Abstract][Full Text] [Related]
30. Metabolic treatment of pregnancy and postdelivery period in a patient with cobalamin A disease. Boneh A; Greaves RF; Garra G; Pitt JJ Am J Obstet Gynecol; 2002 Jul; 187(1):225-6. PubMed ID: 12114914 [TBL] [Abstract][Full Text] [Related]
31. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Andersson HC; Marble M; Shapira E Genet Med; 1999; 1(4):146-50. PubMed ID: 11258350 [TBL] [Abstract][Full Text] [Related]
35. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly. Lewerin C; Ljungman S; Nilsson-Ehle H J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169 [TBL] [Abstract][Full Text] [Related]
36. Common metabolic profile in infants indicating impaired cobalamin status responds to cobalamin supplementation. Bjørke-Monsen AL; Torsvik I; Saetran H; Markestad T; Ueland PM Pediatrics; 2008 Jul; 122(1):83-91. PubMed ID: 18595990 [TBL] [Abstract][Full Text] [Related]
37. Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. Smith SE; Kinney HC; Swoboda KJ; Levy HL Mol Genet Metab; 2006 Jun; 88(2):138-45. PubMed ID: 16574454 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). Andersson HC; Shapira E J Pediatr; 1998 Jan; 132(1):121-4. PubMed ID: 9470012 [TBL] [Abstract][Full Text] [Related]
39. Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect. Dionisi-Vici C; Martinelli D; Ceravolo F; Boenzi S; Pastore A Mol Genet Metab; 2013 Aug; 109(4):329-30. PubMed ID: 23764205 [No Abstract] [Full Text] [Related]
40. Evaluation of prenatal treatment in newborns with cobalamin-responsive methylmalonic acidaemia. Zass R; Leupold D; Fernandez MA; Wendel U J Inherit Metab Dis; 1995; 18(1):100-1. PubMed ID: 7623435 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]